このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Preventing Falls in People Aged Over 75 at High Risk of Falling Through Specific Rehabilitation Involving Walking Backwards (PCRetro)

2026年6月10日 更新者:Assistance Publique - Hôpitaux de Paris

Falls are a major health problem for people over 75 years old. Backward walking may strengthen the muscles of the legs, improve posture and balance, and make walking more stable, which could help prevent new falls and improve everyday movement.

This is an open-label, multicenter, randomized controlled trial that will examine whether backward walking, integrated to usual rehabilitation in a geriatric day hospital program, can help reduce the number of new falls in older adult at high risk of falling.

About 300 people aged over 75 years, living at home and at high risk of falling, will be included in this trial in 11 geriatric day hospitals in France. After receiving appropriate information, those who agree to participate will sign a written consent form and will then be randomly assigned to one of two groups. Both groups will receive standard rehabilitation care in the geriatric day hospital, with two rehabilitation sessions per week for 12 weeks. In the control group, patients will only receive usual care to prevent falls previously described above. In the intervention group, part of the usual care will be replaced, for 5 weeks, by supervised backward walking exercises, with the goal of doing two effective 10 minute backward walking sessions per week, without increasing the total time spent in rehabilitation.

The trial will be conducted under the intention-to-treat principle. Participants will have a clinical visit at day 0, at week 5 and at 6 months, during which clinical information and data related to their usual care and to the study will be collected. All participants will be followed for a total of 12 months, with monthly phone calls from a study team member to record any new falls, hospitalizations, health problems, or other important events. For 10 patients in the intervention group, an individual interview will also be carried out at the 5 week visit to better understand their experience of backward walking. 2 focus groups will be held with 2 randomly selected centers to identify barriers and facilitators to the implementation of backward walking sessions.

This study aims to determine whether adding backward walking to standard rehabilitation is a safe, acceptable and effective way to prevent falls in older adults at high risk of falling.

調査の概要

状態

まだ募集していません

詳細な説明

Justification: Falls are the leading cause of unintentional injuries in the population aged over 75 years in France. Backward walking training has so far been scarcely studied but appears to show promising results compared with conventional rehabilitation across multiple domains. It improves functional capacity, lower limb muscle strength, gait parameters, balance, and stability, all of which are key factors in reducing fall risk. Therefore, we hypothesize that a post-fall rehabilitation program incorporating backward walking sessions may reduce the incidence of falls over one year in high fallrisk risk patients aged over 75 years, compared with a standard rehabilitation program.

Primary objective: The primary objective of the study is to assess the impact of backward walking sessions on the incidence of falls at 1 year in patients aged over 75 years at high risk of falling and managed in a geriatric day hospital, compared with usual care in a geriatric day hospital.

Secondary objectives: The secondary objectives are to assess the effects of backward walking intervention, compared with usual care, on physical and psychological performance as balance, gait speed, functional mobility, fear of falling, and on the occurrence of falls and serious events (time to first fall, all-cause and fall-related hospitalizations, mortality). It also aims to evaluate medium- and long-term quality of life, functional independence, and all-cause hospitalizations, as well as the safety, acceptability, and feasibility of the intervention for patients and the day hospital team.

Settings: The sample size calculation was performed to detect a 35% reduction in the annual incidence rate of falls, assuming a control-group incidence of 1.4-3.6 falls per person-year and accounting for an anticipated 10% loss to follow-up. A total of 300 patients are expected to be enrolled over an 18 month inclusion period, with each patient followed for 12 months. Eleven geriatric centers will participate in the trial.

Experimental design: The PCRetro trial is an open-label, multicenter, randomized controlled, parallel-group clinical trial conducted in a geriatric day hospital rehabilitation setting. The study procedures are as follows: during the geriatric day hospital visit, the investigator will propose participation in the trial to eligible patients after verifying inclusion and exclusion criteria, and will subsequently obtain written informed consent. Patients will then be randomized to the control or intervention arm. Patients in the control arm will undergo two rehabilitation sessions per week for 12 weeks according to usual care. Patients in the intervention arm will undergo two rehabilitation sessions per week for 12 weeks according to usual care, combined with backward walking sessions over 5 weeks. In the intervention arm, backward walking will not increase the overall rehabilitation time but will replace part of usual care in order to achieve two effective 10-minute backward walking sessions per week. Patients will be followed in the same way regardless of their randomization arm, with a medical visit at week 5 and at month 6, and a monthly telephone call by a clinical research assistant blinded to the randomization allocation.

Practical procedures: A screening visit will first be conducted, during which clear and appropriate information about the study will be provided to the patient. This will be followed by an inclusion medical visit, during which written informed consent will be obtained, randomization will be performed, and clinical data as well as routine care data and additional data specific to the PCRetro study will be collected. Patients will then undergo rehabilitation either in the control group, receiving usual care in a geriatric day hospital, or in the intervention group, in which two backward walking activities per week will be integrated over a 5 week period in the usual care. Follow-up medical visits will be scheduled at week 5 and at month 6, during which routine care and additional PCRetro study data will again be collected. The occurrence of falls and intercurrent events will be monitored over 12 months through monthly telephone calls made by a clinical research technician. For 10 patients in the intervention group, a semi-structured interview will also be conducted during the week 5 visit. 2 focus groups will be held with 2 randomly selected centers to identify barriers and facilitators to the implementation of backward walking sessions.

Expected benefits: The primary anticipated benefit is a long-term reduction in the incidence of falls. In the short term, neuromuscular and postural improvements are expected, including increased lower limb muscle strength and better static and dynamic balance, which may translate into higher gait speed, improved functional mobility, and possibly reduced fear of falling. In the medium term, a potential decrease in hospitalization and mortality rates is anticipated. In the long term, these benefits could have a significant positive impact on the quality of life of patients and their caregivers.

Expected risks: No serious adverse events have been reported in studies of backward walking to date. Rare cases of increased joint pain, muscle soreness, and heightened fatigue have been described.

Statistical analysis: It will be conducted under the intention-to-treat principle, with data described and stratified by trial arm using appropriate descriptive statistics. The primary outcome will be analyzed using a Poisson model, with prespecified sensitivity analyses, including adjusted and per-protocol analyses based on a priori defined confounders identified via a Directed Acyclic Graph. Binary secondary outcomes will be summarized as odds ratios with 95% confidence intervals, while continuous secondary outcomes will be analyzed using parametric or non-parametric tests as appropriate. Time-to-event endpoints will be examined using Kaplan-Meier curves and Cox proportional hazards models, with results expressed as hazard ratios and 95% confidence intervals. Missing data will be handled in line with current recommendations and the predefined estimand framework. Qualitative data from focus groups and semi-structured interviews will be analyzed independently by two researchers using a Grounded Theory-inspired approach and interpreted within the Normalization Process Theory framework.

研究の種類

介入

入学 (推定)

300

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究場所

      • Ivry-sur-Seine、フランス、94205
        • Hôpital Charles-Foix
        • コンタクト:

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 高齢者

健康ボランティアの受け入れ

いいえ

説明

Inclusion Criteria:

  • People aged over 75
  • Consultant at a geriatric day hospital
  • At high risk of falling. High risk of falling is defined in accordance with the World guidelines for falls prevention and management for older adults: a global initiative. The patient must have at least one of the following characteristics:

    • At least two falls in the last 12 months;
    • A fall resulting in an injury requiring medical attention;
    • Inability to get up unaided after a fall for at least one hour;
    • Suspected syncope;
    • Frailty (Clinical Frailty Scale ≥4)
  • Able to walk on a treadmill (physically able and capable of understanding the physiotherapist's instructions)
  • Able to understand and follow instructions from healthcare professionals
  • Patient or guardian who has been informed about the study and has given their free, informed and written consent to participate
  • Covered by a social security scheme (member or beneficiary) excluding Aide Médicale d'Etat (AME).

Exclusion Criteria:

  • Acute medical condition incompatible with prolonged standing (at the inclusion visit)
  • Estimated life expectancy of less than one year (at the inclusion visit)
  • Participation in another interventional trial or being within the exclusion period following a previous trial, where applicable (at the inclusion visit)
  • Balance disorders related to vestibular and cerebellar disorders (at the inclusion visit).

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:防止
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
実験的:Walking backwards
Standard care combined with rehabilitation sessions involving walking backwards. Ten rehabilitation sessions involving walking backwards are scheduled, at a rate of two sessions per week for five weeks, on a secure treadmill designed for walking backwards. Walking backwards will not add to the rehabilitation time; it will replace standard care to allow for two 10-minute sessions of actual walking backwards per week. Walking backwards are integrated to the 12 weeks standard program.
アクティブコンパレータ:Usual walking
The standard program runs for 12 weeks, with sessions twice a week, comprising two 45-minute activities per day. At least one session per week must include balance training, muscle strengthening and multi-modal exercises. The treadmill may be used for these activities, but only for walking forwards.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Number of falls per patient between inclusion and one year of follow-up including rehabilitation period in a geriatric day hospital
時間枠:12 months after inclusion
Number of falls per patient
12 months after inclusion

二次結果の測定

結果測定
メジャーの説明
時間枠
Balance assessment
時間枠:At inclusion, Week 5 and 6 months
Balance assessed using the Berg Scale
At inclusion, Week 5 and 6 months
Assessment of walking speed
時間枠:At inclusion, Week 5 and 6 months
Walking speed assessed using the 4-metre walk test
At inclusion, Week 5 and 6 months
Measuring fear of falling
時間枠:At inclusion, Week 5 and 6 months
Fear of falling measured using the Short Falls Efficacy Scale International (Short-FES-I)
At inclusion, Week 5 and 6 months
Assessment of functional mobility
時間枠:At inclusion, Week 5 and 6 months
Functional mobility assessed using the Time-up and Go test
At inclusion, Week 5 and 6 months
Time to first fall in days
時間枠:From inclusion to 12 months (monthly)
Telephone follow-up of the patient by a clinical research technician
From inclusion to 12 months (monthly)
Hospitalisation for any cause and due to a fall
時間枠:From inclusion to 12 mois (monthly)
Telephone follow-up of the patient by a clinical research technician
From inclusion to 12 mois (monthly)
Vital status
時間枠:From inclusion to 12 months (monthly)
Telephone follow-up of the patient by a clinical research technician
From inclusion to 12 months (monthly)
Quality of life score
時間枠:At inclusion, Week 5 and 6 months
Quality of life score will be assessed by the scale EuroQol - 5 Dimensions - 5 Levels (EQ-5D-5L scale)
At inclusion, Week 5 and 6 months
Assessment of independence
時間枠:At inclusion, Week 5 and 6 months
Independence measured using the ADL scale
At inclusion, Week 5 and 6 months
Assessment of independence
時間枠:At inclusion, Week 5 and 6 months
Independence measured using the iADL scale
At inclusion, Week 5 and 6 months
Assessment of user feedback
時間枠:At Week 5
User feedback measured using the F-SUS questionnaire (for the intervention arm only)
At Week 5
Intercurrent events
時間枠:At Week 1, Week 2, Week 3, Week 4, Week 5
Intercurrent events at home and any incidents, including the number of patients wishing to stop the sessions or withdraw from the trial during each session, measured at each session by a doctor or physiotherapist
At Week 1, Week 2, Week 3, Week 4, Week 5
Completion of 80% of sessions by at least 80% of enrolled patients
時間枠:At Week 5
Measurement taken during a consultation by a doctor
At Week 5
Assessment of satisfaction and acceptability of backward walking
時間枠:No later than 1 month after Week 5
Satisfaction and acceptability of backward walking assessed through 10 semi-structured individual interviews with included patients (intervention arm)
No later than 1 month after Week 5
Barriers and facilitators to the implementation of backward walking sessions
時間枠:No later than 1 month after the end of follow-up for the last patient included
Barriers and facilitators to the implementation of backward walking sessions identified during 2 focus groups with teams (doctors, nurses, physiotherapists, adapted physical activity (APA) professionals, occupational therapists and psychomotor therapists)
No later than 1 month after the end of follow-up for the last patient included

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

捜査官

  • 主任研究者:Bruno OQUENDO, Dr、Hôpital Charles-Foix - Assistance Publique Hôpitaux de Paris

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年9月15日

一次修了 (推定)

2029年3月15日

研究の完了 (推定)

2029年3月15日

試験登録日

最初に提出

2026年6月10日

QC基準を満たした最初の提出物

2026年6月10日

最初の投稿 (実際)

2026年6月16日

学習記録の更新

投稿された最後の更新 (実際)

2026年6月16日

QC基準を満たした最後の更新が送信されました

2026年6月10日

最終確認日

2026年6月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • APHP251245
  • 2025-A02896-43 (その他の識別子:ANSM)

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

はい

IPD プランの説明

The procedures carried out with the French data privacy authority (CNIL, Commission nationale de l'informatique et des libertés) do not provide for the transmission of the database, nor do the information and consent documents signed by the patients.

Consultation by the editorial board or interested researchers of individual participant data that underlie the results reported in the article after deidentification may nevertheless be considered, subject to prior determination of the terms and conditions of such consultation and in respect for compliance with the applicable regulations.

IPD 共有時間枠

Beginning 3 months and ending 3 years following article publication. Requests out of these time frame can also be submitted to the sponsor

IPD 共有アクセス基準

Researchers who provide a methodologically sound proposal

IPD 共有サポート情報タイプ

  • STUDY_PROTOCOL
  • SAP
  • ICF

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

転倒の危険性が高いの臨床試験

  • Institute of Hematology & Blood Diseases Hospital...
    Hebei Taihe Chunyu Biotechnology Co., Ltd
    募集
    形質細胞白血病 | Ultra High Risk MM(UHR-MM)、18〜70歳、ASCTに適しています。次のUHR-MM定義のいずれかを満たします | 細胞遺伝学の超高リスク | 一次難治 | 早期進行 | 非麻痺性髄外浸潤 | R2-ISS-IV /MPSS-IV
    中国

Walking backwardsの臨床試験

購読する